Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

Why Are Lonmin Plc, Oxford BioMedica plc & Bango plc Among Today’s Biggest Gainers?

Should you buy or sell these 3 major gainers? Lonmin Plc (LON: LMI), Oxford BioMedica plc (LON: OXB) and Bango plc (LON: BGO)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Lonmin (LSE: LMI) have soared by over 5% today after the mining company announced the appointment of a new CFO. Barrie van der Merwe will take over on 17 May and the market seems to have welcomed this prompt decision by the company following the resignation of Simon Scott.

Clearly, this is a time of major change for Lonmin as it seeks to implement an updated strategy in response to exceptionally difficult trading conditions. As part of this, it is restructuring its business and also seeking to cut costs; both of which are likely to have a positive impact on Lonmin’s bottom line over the medium to long term. And with Lonmin having the capital through which to effect its new plan following last year’s fundraising, its future seems to be brighter than it was just a handful of months ago.

This increased confidence plus a more stable commodity price environment has led to a rise in Lonmin’s share price of 99% since the turn of the year. This rapid increase could continue, although Lonmin remains a relatively high risk play and may only be of interest to less risk averse investors.

Also rising today are shares in Oxford BioMedica (LSE: OXB), with them being up over 11% despite no significant news flow having been released by the company today. In fact, the gene therapy specialist has not released an update since 7 March when it announced a new and expanded collaboration with Immune Design Corp. Since then its shares have fallen by around 6% but looking ahead, the company has clear potential to deliver profitability.

The challenge for investors, though, is that profitability may still be a long way off. And in the meantime Oxford BioMedica is in a cash burn phase which could require further fundraisings following its £8.1m placing in February. As such, and while Oxford BioMedica has a bright long term future in a very appealing space, it may only be worth a closer look for less risk averse investors.

Meanwhile, shares in mobile payments company Bango (LSE: BGO) have risen by 12% today despite a lack of news flow. Despite this, its shares have still fallen by 60% since the turn of the year even though Bango’s full-year results have showed that it is making progress. For example, it experienced significant growth in end user spend, with the company also doubling the rate of spending through the Bango payment platform. And with a stable cost base, it seems to be well-positioned to move towards profitability.

Of course, the market seems to be somewhat downbeat on Bango’s prospects judging by its recent share price fall. While today’s upward movement could indicate a change in sentiment, it may be prudent to await confirmation of this over the medium term before piling in.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Forget high yields? Here’s the smart way to build passive income with dividend shares

Stephen Wright outlines how investors looking for passive income can put themselves in the fast lane with dividend shares.

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

15,446 Diageo shares gets me a £1,000 monthly second income. Should I?

Diageo has been a second-rate income stock for investors over the last few years. But the new CEO sees potential…

Read more »

Investing Articles

2 FTSE 100 stocks to target epic share price gains in 2026!

Looking for blue-chip shares to buy? Discover which two FTSE 100 stocks our writer Royston Wild thinks could explode in…

Read more »

A row of satellite radars at night
Investing Articles

If the stock market crashes in 2026, I’ll buy these 2 shares like there’s no tomorrow

These two shares have already fallen 25%+ in recent weeks. So why is this writer wating for a stock market…

Read more »

British Pennies on a Pound Note
Investing Articles

How much money does someone really need to start buying shares?

Could it really be possible to start buying shares with hundreds of pounds -- or even less? Christopher Ruane weighs…

Read more »

Two gay men are walking through a Victorian shopping arcade
Investing Articles

With Versace selling for £1bn, what does this tell us about the valuations of the FTSE 100’s ‘fashionable’ stocks?

Reflecting on the sale of Versace, James Beard reckons the valuations of the FTSE 100’s fashion stocks don’t reflect the…

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

Want to stuff your retirement portfolio with high-yield shares? 5 to consider that yield 5.6%+

Not everyone wants to have a lot of high-yield shares in their portfolio. For those who might, here's a handful…

Read more »

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

How much do you need in a SIPP to target a £3,658 monthly passive income?

Royston Wild discusses a 9.6%-yielding fund that holds global stocks -- one he thinks could help unlock an enormous income…

Read more »